← Back to headlines
Innovent and Eli Lilly Partner to Commercialize Verzenios in China
Innovent Biologics and Eli Lilly have partnered to commercialize Verzenios (abemaciclib) in China, expanding access to the cancer treatment in the region.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
